Please login to the form below

Not currently logged in
Email:
Password:

Grayling CEO Pete Pedersen resigns

He steps down after two years in role at Huntsworth company

Pete PedersenPete Pedersen has resigned from his role as CEO at communications company Grayling

Grayling's parent company Huntsworth released a statement last week that thanked Pedersen for repositioning the firm as a “digitally focused international PR company” and wishing him the best for the future. The executive management team of Grayling will manage the company on a day-by-day basis.

No official reason was given for Pedersen's departure although he did say on Twitter: “Resigned today. Time for my next great adventure. Best of luck to the entire @graylingpr team. Keep moving #onward.”

Huntsworth is already dealing with changes at the top with the decision by CEO Lord Chadlington to retire in April. It will be down to his successor Paul Taaffe to lead the hunt for a new CEO of Grayling, which works across numerous industries including healthcare.

Pederson joined Grayling in February 2013 after leaving his role as chair of the global technology practice at PR firm Edelman. Prior to this he served as executive VP and global client leader at Edelman where he led the launches of Microsoft products Xbox 360 and Halo 2.

26th January 2015

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Healthcircle

We're Healthcircle – an award-winning healthcare advertising and creative communications agency, offering a holistic approach to brand health. With a...

Latest intelligence

What challenges still face clinical trial recruitment and retention?
Discover the reasons for the current clinical trial recruitment challenges facing pharma and the life sciences industry, and how the search for solutions to the problem continues...
“Fake News” and Credibility in Medical Publishing
Natalie Yeadon from Impetus Digital shares her thoughts on fighting fake news in Pharma and healthcare....
Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...

Infographics